Autophagy can contribute to cell death when combining targeted therapy

Cancer Biology and Therapy

Volumn 8, Issue 21, 2009, Pages 2097-2100

  Amaravadi, Ravi ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Autophagy; Bcl2 family; ErbB receptor family; Lapatinib; Obatoclax

Indexed keywords

APOPTOSIS INDUCING FACTOR; BECLIN 1; CASPASE; CYTOCHROME C; EPIDERMAL GROWTH FACTOR RECEPTOR; LAPATINIB; MAMMALIAN TARGET OF RAPAMYCIN; OBATOCLAX; PROTEIN BAK; PROTEIN BAX; PROTEIN MCL 1; SURVIVIN; X LINKED INHIBITOR OF APOPTOSIS;

APOPTOSIS; AUTOPHAGY; BREAST CANCER; CELL DEATH; CELL STRAIN HCT116; COLON CANCER; CONTROLLED STUDY; DRUG EXPOSURE; DRUG POTENTIATION; ENZYME ACTIVATION; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; NOTE; OLIGOMERIZATION; PROTEIN PROTEIN INTERACTION; RECEPTOR UPREGULATION;

EID: 73549095971     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.8.21.10416     Document Type: Note

References (18)

1. Martin AMC, Rahmani M, Nephew K, Grant S, Dent P. Inhibitin of MCL-1 enhances Lapatnib toxicity and overcomes Lapatinib resistance via BAK-dependent autophagy. Cancer Biol Ther 2009;
2. Martin AP, Miller A, Emad L, Rahmani M, Walker T, Mitchell C, et al. Lapatinib resistance in HCT116 cells is mediated by elevated MCL-1 expression and decreased BAK activation and not by ERBB receptor kinase mutation. Mol Pharmacol 2008; 74:807-22.
3. Kang MH, Reynolds CP. Bcl-2 inhibitors: targeting mitochondrial apoptotic pathways in cancer therapy. Clin Cancer Res 2009; 15:1126-32.
4. Ravikumar B, Futter M, Jahreiss L, Korolchuk VI, Lichtenberg M, Luo S, et al. Mammalian macroautophagy at a glance. J Cell Sci 2009; 122:1707-11.
5. Amaravadi RK, Thompson CB. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res 2007; 13:7271-9.
6. Jung CH, Jun CB, Ro SH, Kim YM, Otto NM, Cao J, et al. ULK-Atg13-FIP200 complexes mediate mTOR signaling to the autophagy machinery. Mol Biol Cell 2009; 20:1992-2003.
7. Sinha S, Levine B. The autophagy effector Beclin 1: a novel BH3-only protein. Oncogene 2008; 27 Suppl 1:S137-48.
8. Balgi AD, Fonseca BD, Donohue E, Tsang TC, Lajoie P, Proud CG, et al. Screen for chemical modulators of autophagy reveals novel therapeutic inhibitors of mTORC1 signaling. PLoS One 2009; 4:e7124.
9. Amaravadi RK, Yu D, Lum JJ, Bui T, Christophorou MA, Evan GI, et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest 2007; 117:326-36.
10. Tanida I, Ueno T, Kominami E. LC3 conjugation system in mammalian autophagy. Int J Biochem Cell Biol 2004; 36:2503-18.
11. Steiger-Barraissoul S, Rami A. Serum deprivation induced autophagy and predominantly an AIF-dependent apoptosis in hippocampal HT22 neurons. Apoptosis 2009.
12. Amaravadi R, Thompson CB. The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest 2005; 115:2618-24.
13. Aird KM, Ding X, Baras A, Wei J, Morse MA, Clay T, et al. Trastuzumab signaling in ErbB2-overexpressing inflammatory breast cancer correlates with X-linked inhibitor of apoptosis protein expression. Mol Cancer Ther 2008; 7:38-47.
14. Boya P, Kroemer G. Lysosomal membrane permeabilization in cell death. Oncogene 2008; 27:6434-51.
15. Saftig P, Klumperman J. Lysosome biogenesis and lysosomal membrane proteins: trafficking meets function. Nat Rev Mol Cell Biol 2009; 10:623-35.
16. Joza N, Pospisilik JA, Hangen E, Hanada T, Modjtahedi N, Penninger JM, et al. AIF: not just an apoptosis-inducing factor. Ann N Y Acad Sci 2009; 1171:2-11.
17. Amaravadi RK. Autophagy-induced tumor dormancy in ovarian cancer. J Clin Invest 2008.
18. Lu Z, Luo RZ, Lu Y, Zhang X, Yu Q, Khare S, et al. The tumor suppressor gene ARHI regulates autophagy and tumor dormancy in human ovarian cancer cells. J Clin Invest 2008; 118:3917-29.